ASML reports €5.3 billion total net sales and €1.2 billion net income in Q1 2024
April 17, 2024 01:00 ET
|
ASML Netherlands BV
ASML reports €5.3 billion total net sales and €1.2 billion net income in Q1 20242024 outlook unchanged VELDHOVEN, the Netherlands, April 17, 2024 – Today, ASML Holding NV (ASML) has...
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
April 17, 2024 00:30 ET
|
TScan Therapeutics, Inc.
WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered...
ハット8 (Hut 8)、マイナーがソルトクリークでオンラインになり、セルフマイニング操作を最適化
April 16, 2024 23:07 ET
|
Hut 8 Corp.
起工から3ヵ月に満たない78日でグリーンフィールド施設に電力を供給 エネルギープロファイルが良好であるため、施設でビットコインをマイニングするコストは、ホスト施設でのコストよりも30%低いと予想 マイアミ発, April 17, 2024 (GLOBE NEWSWIRE) --...
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
April 16, 2024 20:01 ET
|
Acrivon Therapeutics, Inc
WATERTOWN, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision...
Millicom’s Nomination Committee’s proposal for Board of Directors
April 16, 2024 20:00 ET
|
Millicom International Cellular S.A.
Millicom’s Nomination Committee’s proposal for Board of Directors Luxembourg, April 17, 2024 – In advance of the Annual General Meeting of shareholders (“AGM”) of Millicom International Cellular...
Convening Notice for Annual General Meeting and Extraordinary General Meeting of Shareholders
April 16, 2024 20:00 ET
|
Millicom International Cellular S.A.
Convening Notice for Annual General Meeting and Extraordinary General Meeting of Shareholders MILLICOM INTERNATIONAL CELLULAR S.A.Registered Address: 2, Rue du Fort BourbonL-1249 Luxembourg, Grand...
Beam Global Reports Record Year End 2023 Operating Results
April 16, 2024 19:02 ET
|
Beam Global
Beam Global Reports Record Year End 2023 Operating Results
James River Completes Sale of Casualty Reinsurance Business to Fleming Holdings
April 16, 2024 18:35 ET
|
James River Group Holdings, Ltd.
PEMBROKE, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) today announced that Fleming Intermediate Holdings (“Fleming”)...
Beam Global to Release 2023 Operating Results, Conference Call Scheduled for April 17, 2024 at 4:30 p.m. ET
April 16, 2024 18:34 ET
|
Beam Global
Beam Global to Release 2023 Operating Results, Conference Call Scheduled for April 17, 2024 at 4:30 p.m. ET
Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 16, 2024 18:21 ET
|
Nurix Therapeutics, Inc.
SAN FRANCISCO, April 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the closing of its underwritten public offering of 11,916,667 shares of its common stock at...